PeptidePedia The community reference

Topic portal·0 articles

Portal:Adverse effects

Harms, with their denominators

Introduction

An adverse-effect figure without its comparator rate and its source is close to meaningless. This portal collects the harm articles, each of which is written to give the trial incidence, the placebo rate, and the study the pair comes from — and to distinguish randomised evidence from pharmacovigilance signals, observational analyses and case reports.

Where a risk is genuinely contested, the article describes the dispute rather than settling it.

Picture of the month

0.25wk 1–40.5wk 5–81.0wk 9–121.7wk 13–162.4wk 17+mg/wklabel dose-escalation schedule
A label dose-escalation schedule. Most gastrointestinal adverse events cluster around the dose increases.

Articles in this portal

No articles yetThe categories this portal draws on are currently empty.

Things you can do

  • Add the comparator rate to any incidence figure currently given alone.
  • Review the litigation-related material for neutrality.

Items here are deliberately small enough to finish in one sitting. See Project:Verifiability before adding sources.